Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 683 of 6351
-
Simple blood test could spot hidden heart risk in kids
Diagnosis Recruiting nowFamilial hypercholesterolemia is the most common treatable genetic disorder for which a simple, effective treatment is available, with few side effects. It leads to a significant increase in LDL levels, generally in excess of 1.9g/l, including in children. It is much higher than…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to heal gut in Crohn's patients
Disease control Recruiting nowThe main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely ac…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain zaps for war trauma? new TMS study hints at faster PTSD relief
Symptom relief CompletedPosttraumatic stress disorder (PTSD) among military service members and veterans is as high as 32% and is the third most service-connected disability, resulting in over $1.5 billion in direct costs over a five-year period. According to Clinical Practice Guidelines, strong evidenc…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Nasal spray could shrink polyps and reduce need for surgery
Disease control CompletedThe goal of this study is to evaluate whether a nasal spray containing adelmidrol, a mast cell modulator and precursor of palmitoylethanolamide, can reduce inflammation, improve symptoms, and decrease nasal polyp size in patients with chronic rhinosinusitis with nasal polyps. The…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can Weight-Loss drugs outperform diet and exercise for heart health?
Disease control Recruiting nowThis study examines how two different weight-loss strategies affect heart and metabolic health, as well as changes at the molecular level in the body. One group includes adults who are starting a GLP-1 receptor agonist medication (i.e., semaglutide or tirzepatide) prescribed by t…
Sponsor: Texas Tech University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a tailored diet quiet the burn of acid reflux?
Symptom relief Recruiting nowGastroesophageal reflux disease (GERD) is a common gastrointestinal disorder, with around 80% of patients experiencing nighttime symptoms. The prolonged nighttime reflux increases esophageal acid exposure, leading to complications like erosive esophagitis and extra-esophageal sym…
Sponsor: Hualien Tzu Chi General Hospital • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to help At-Risk youth prevent HIV and get substance use support
Disease control Recruiting nowA randomized controlled trial to assess the ability of a Collaborative Care Prevention, Treatment, Navigation, Engagement, Resource (PrTNER) intervention to increase initiation of preexposure prophylaxis (PrEP) (for those at-risk for HIV) and decrease viral load (for those living…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Lab-Grown tumors may pick best drug for bladder cancer patients
Disease control Recruiting nowThis study, through a clinical controlled trial, compares the one-year, two-year, and three-year overall survival rates of patients in the treatment group guided by organoid drug sensitivity intervention with those of patients whose medication was based on HER-2 protein expressio…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Brain pacemaker trial aims to lift severe bipolar depression
Disease control Recruiting nowThis study is only enrolling at Baylor College of Medicine. The other research locations listed serve to support data analysis only. This research study is to investigate the use of technology called Deep Brain Stimulation (DBS) to potentially improve Treatment-Resistant Bipolar…
Sponsor: Wayne Goodman MD • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug duo aims to slash leukemia relapse after bone marrow transplant
Disease control Recruiting nowThis study aims to determine whether the recurrence rate of high-risk acute myeloid leukemia CR1 patients who received allogeneic hematopoietic stem cell transplantation with the Ruxolitinib, Decitabine combined with Bu/Cy or BuF intensive pretreatment regimen is reduced compared…
Phase 4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a virus injection stop oral cancer before it starts?
Prevention Recruiting nowThe goal of this study is to understand the safety, tolerability, and potential efficacy of an injected immune therapy called RP2 to treat oral precancer conditions and prevent progression to an oral cancer. The name of the study drug involved in this study is: -RP2 (a genetica…
Phase 2 • Sponsor: Glenn J. Hanna • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New peptide aims to flush out hidden HIV in early trial
Disease control OngoingThe goal of this phase II, open-label, randomized, controlled clinical trial is to evaluate the impact of Gammora®, a 16-mer HIV integrase-derived peptide associated with a boosted darunavir antiretroviral regimen compared Gammora® arm) to a boosted darunavir antiretroviral regim…
Phase 2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New blood filter could save lives in septic shock
Disease control By invitation onlyThere is a lack of evidence in the efficacy of extracorporeal blood purification (EBP) to reduce the mortality rate in septic shock. We have designed the EABPSS (Efficacy of Adaptive Blood Purification for Septic Shock) study to confirm whether adaptive blood purification (ABP) i…
Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Herbal blend and probiotics: a new hope for stubborn constipation?
Disease control CompletedSlow transit constipation (STC) is a common and difficult-to-treat subtype of chronic constipation, characterized by reduced colonic motility and delayed stool passage. Current treatments often provide limited long-term relief, and many patients relapse after stopping medication.…
Sponsor: First People's Hospital Of Lin'an District, Hangzhou • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New study explores surgery hope for inoperable pancreatic cancer
Knowledge-focused Recruiting nowPancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and…
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
AI reads your Heart's electrical signals to spot hidden disease
Diagnosis Recruiting nowBy harnessing artificial intelligence to decode the 12-lead electrocardiogram, the project will enable precise ECG-based phenotyping of hypertrophic cardiomyopathy-accurately classifying septal, apical, and other morphologic subtypes-while simultaneously differentiating HCM from …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Which diabetes drug protects the heart better? large study aims to find out
Disease control OngoingThis cohort study aims to assess the comparative effectiveness of tirzepatide versus semaglutide with respect to cardiovascular events in patients with type 2 diabetes and heart failure with preserved ejection fraction.
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo aims to outsmart resistant lung cancer
Disease control Recruiting nowOsimertinib combined with savolitinib in the treatment of EGFR mutated osimertinib resistant NSCLC with low copy number MET amplification There are unmet medical needs in patients who resist to to osimertinib; savolitinib plus osimertinib shows high response rate and prolong prog…
Phase 2 • Sponsor: Qingdao Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
AI reads faces to diagnose rare genetic diseases
Diagnosis Recruiting nowThe field of artificial intelligence is booming in medicine and in the field of diagnosis. The data can be varied: x-rays, pathology sections, or photographs. It is considered that 30 to 40% of the 7000 rare diseases described to date cause craniofacial dysmorphia. Their detecti…
Sponsor: Imagine Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to shrink unresectable bile duct tumors
Disease control Recruiting nowIntrahepatic cholangiocarcinoma (ICC) has a poor prognosis. The aim of this study is to investigate the efficacy and safety of GP-HAIC combined with immunosuppressants in the treatment of initially unresectable ICC patients, as well as its role in conversion therapy. A prospectiv…
Phase 2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC